Feasibility, safety and efficacy of COVID-19 severe acute respiratory distress syndrome management without invasive mechanical ventilation.
Minerva Anestesiol
; 89(11): 1013-1021, 2023 11.
Article
em En
| MEDLINE
| ID: mdl-37733369
ABSTRACT
BACKGROUND:
COVID-19 acute respiratory distress syndrome (ARDS) is often managed with mechanical ventilation (MV), requiring sedation and paralysis, with associated risk of complications. There is limited evidence on the use of high flow nasal cannula (HFNC). We hypothesized that management of COVID-19 ARDS without MV is feasible.METHODS:
Included were all adult patients diagnosed with COVID-19 ARDS, with PaORESULTS:
Out of 118 patients, 41 were managed only with HFNC from hospital admission (and at least during first 24 hours in ICU) and had a PaOCONCLUSIONS:
It is safe to monitor in ICU and use HFNC in patients affected by COVID-19 ARDS who initially present data suggesting an early need for intubation. The 41 patients admitted with a PaO
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Síndrome do Desconforto Respiratório
/
Insuficiência Respiratória
/
Ventilação não Invasiva
/
COVID-19
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article